Suppr超能文献

中年至老年健康志愿者中透皮芬太尼与透皮丁丙诺啡皮肤刺激潜力的比较。

A comparison of the skin irritation potential of transdermal fentanyl versus transdermal buprenorphine in middle-aged to elderly healthy volunteers.

作者信息

Schmid-Grendelmeier Peter, Pokorny Rolf, Gasser Urs E, Richarz Ute

机构信息

University Hospital of Zurich, Zurich, Switzerland.

出版信息

Curr Med Res Opin. 2006 Mar;22(3):501-9. doi: 10.1185/030079906X89829.

Abstract

OBJECTIVE

Establishing local tolerability of transdermal opioid systems is important as more systems become available for use in a range of indications. We compared the skin irritation potential of a single application of transdermal fentanyl (Durogesic D-trans; DDTDF) and transdermal buprenorphine (Transtec; TDB) patches in healthy volunteers.

METHODS

46 healthy males and females (mean age [range]: 59.6 [50-69] years) with healthy skin received a single dose of both the DDTDF 25 mug/h patch and the TDB 35 mug/h patch in a randomised order under naltrexone cover. The incidence and severity of erythema was assessed at various timepoints after patch removal.

RESULTS

There was a non-significant trend towards a higher incidence of erythema 60 min after patch removal with TDB compared with DDTDF. The severity of erythema at 60 min and the incidence of erythema at 72 h after patch removal were significantly higher with TDB than with DDTDF (p = 0.01 and 22% versus 4.9%, p = 0.04, respectively). In general, the results from the chromametric assessment of treated skin were in agreement. The incidence of topical adverse events (AEs) was lower with DDTDF than with TDB (one versus six events) and subjects preferred the DDTDF patch and felt it was less noticeable on the skin. The DDTDF patch was considered less painful to remove, and, consistent with that, the TDB patch was judged to have better adhesion. Twenty-one subjects reported systemic AEs with DDTDF plus naltrexone and 22 with TDB plus naltrexone, most of which were considered treatment-related, 34 and 60 AEs, respectively.

CONCLUSIONS

Local tolerability of transdermal opioid systems should be considered when making a therapeutic choice. Even after a single application in healthy volunteers, differences in local tolerability, assessed both clinically and by chromametry, and patch comfort were shown between DDTDF and TDB, in favour of DDTDF.

摘要

目的

随着越来越多的透皮阿片类药物系统可用于一系列适应症,确定其局部耐受性很重要。我们比较了健康志愿者单次使用透皮芬太尼(多瑞吉D - trans;DDTDF)和透皮丁丙诺啡(曲坦西;TDB)贴剂后的皮肤刺激可能性。

方法

46名皮肤健康的男性和女性(平均年龄[范围]:59.6[50 - 69]岁)在纳曲酮覆盖下,以随机顺序接受了单剂量的DDTDF 25微克/小时贴剂和TDB 35微克/小时贴剂。在去除贴剂后的不同时间点评估红斑的发生率和严重程度。

结果

与DDTDF相比,去除TDB贴剂60分钟后红斑发生率有升高趋势,但无统计学意义。去除贴剂60分钟时红斑的严重程度以及去除贴剂72小时后红斑的发生率,TDB均显著高于DDTDF(分别为p = 0.01,TDB为22%,DDTDF为4.9%,p = 0.04)。总体而言,对治疗皮肤的色度测定评估结果一致。DDTDF的局部不良事件(AE)发生率低于TDB(分别为1例和6例),受试者更喜欢DDTDF贴剂,感觉其在皮肤上不太明显。DDTDF贴剂被认为去除时疼痛较轻,与此一致的是,TDB贴剂被判定粘性更好。21名受试者报告了DDTDF加纳曲酮后的全身性AE,22名受试者报告了TDB加纳曲酮后的全身性AE,其中大多数被认为与治疗相关,分别为34例和60例AE。

结论

在做出治疗选择时应考虑透皮阿片类药物系统的局部耐受性。即使在健康志愿者中单次使用后,通过临床和色度测定评估的局部耐受性以及贴剂舒适度在DDTDF和TDB之间也存在差异,DDTDF更具优势。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验